Search

Displaying results 8431 - 8440 of 10000 in total
  1. Drug

    ORG-25935

    go.drugbank.com/drugs/DB12220
    Investigational

    Org 25935 has been used in trials studying the treatment of Alcoholism, Schizophrenia, and Panic Disorder.

  2. Drug

    Brilanestrant

    go.drugbank.com/drugs/DB12253
    Investigational

    ARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.

  3. Drug

    CRS-3123

    go.drugbank.com/drugs/DB12262
    Investigational

    CRS3123 has been used in trials studying the treatment of Clostridial Infection and Clostridium Difficile Colitis.

  4. Drug

    SCY-635

    go.drugbank.com/drugs/DB12451
    Investigational

    SCY-635 has been investigated for the treatment of Chronic Hepatitis C and Hepatitis C Infection.

  5. Drug

    Dexelvucitabine

    go.drugbank.com/drugs/DB12470
    Investigational

    Dexelvucitabine has been used in trials studying the treatment of HIV Infections and Human Immunodeficiency Virus.

  6. Drug

    PD-217014

    go.drugbank.com/drugs/DB12493
    Investigational

    PD-217,014 has been used in trials studying the treatment of Pain and Irritable Bowel Syndrome.

  7. Drug

    Seletalisib

    go.drugbank.com/drugs/DB12706
    Investigational

    Seletalisib has been used in trials studying the treatment and basic science of Primary Sjogren's Syndrome.

  8. Drug

    Psicose

    go.drugbank.com/drugs/DB15087
    Experimental

    Psicose is under investigation in clinical trial NCT02459834 (The Fructose and Allulose Catalytic Effects (FACE) Trial).

  9. Drug

    NVS antibody

    go.drugbank.com/drugs/DB05312
    Experimental

    This drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.

  10. Drug

    COVID-19 convalescent plasma

    go.drugbank.com/drugs/DB15692
    Investigational

    [L14333] Although there are no formal clinical trial results for the safety or efficacy of COVID-19 convalescent plasma, early results from 5000 patients under the FDA expanded access program suggest … COVID-19 convalescent plasma is plasma collected from patients who have acquired and subsequently recovered from COVID-19 and which contains antibodies against the causative agent SARS-CoV-2.